Breaking News Instant updates and real-time market news.

RDUS

Radius Health

$37.57

0.8 (2.18%)

10:06
10/13/17
10/13
10:06
10/13/17
10:06

Rumor: Radius Health moves up on renewed takeover chatter

  • 02

    Nov

RDUS Radius Health
$37.57

0.8 (2.18%)

05/02/17
COWN
05/02/17
DOWNGRADE
COWN
Market Perform
Radius Health downgraded to Market Perform from Outperform at Cowen
Cowen analyst Chris Shibutani downgraded Radius Health to Market Perform due to fewer near-term drivers following a proprietary expert survey regarding the outlook for Tymlos. The analyst said Tymolos has attractive features versus Forteo but differentiation is relatively limited and physicians expressed concerns over pricing and reimbursement. Further, Amgen's romosozumab's potential approval near-term and the potential entry of Forteo generic/biosimilar long-term are potential competitive threats.
05/22/17
JPMS
05/22/17
NO CHANGE
Target $74
JPMS
Overweight
Amgen data a 'clear positive' for Radius Health, says JPMorgan
JPMorgan analyst Jessica Fye believes the imbalance in observed cardiovascular serious adverse events reported by Amgen (AMGN) and UCB over the weekend for Evenity is a "clear positive" for Radius Health (RDUS). The FDA will now add results from the Phase 3 ARCH study to the regulatory review, and as a result Amgen does not expect U.S. approval for Evenity in 2017, Fye tells investors in a research note. The update is a "clear positive" for Radius Health, who has Tymlos already approved with a clean clinical safety profile, the analyst contends. She continues to believe Tymlos is well positioned for a successful launch into the large market opportunity of postmenopausal women with osteoporosis at high risk of fracture. Fye has an Overweight rating on Radius with a $74 price target. The stock in premarket trading is up 13%, or $4.62, to $39.55.
05/22/17
LEER
05/22/17
NO CHANGE
Target $159
LEER
Market Perform
Leerink sees only 50/50 chance of Amgen's Evenity hitting market
After Amgen (AMGN) and UCB reported an "imbalance of positively adjudicated serious cardiovascular adverse events" in its Phase 3 study of Evenity, Leerink analyst Geoffrey Porges believes the product now has only a 50/50 probability of coming to market at all. The analyst lowered his price target for Amgen shares to $159 from $160 and keeps a Market Perform rating on the name. Radius Health (RDUS), which has a drug that would compete with Evenity, is trading up 16% to $40.58 in the premarket.
05/22/17
ADAM
05/22/17
NO CHANGE
Target $85
ADAM
Buy
CV events 'may kill' Amgen's romosozumab development, says Canaccord
Canaccord analyst John Newman said Amgen (AMGN) and partner UCB's report of a higher rate of cardiovascular Serious Adverse Events for romosozumab in the Phase 3 ARCH study in osteoporosis suggests a much lower chance of FDA approval for the drug and may "kill" romosozumab's development. He notes that Merck's (MRK) cathepsin-K inhibitor was previously discontinued due to increased risk of atrial fibrillation and stroke. In addition to the safety signals, Newman points out that romosozumab was worse than Radius' (RDUS) Tymlos for non-vertebral fracture and for vertebral fracture, suggesting Radius' drug also has much better efficacy, said the analyst, who keeps a Buy rating and $85 price target on Radius Health shares, which are up $4.47, or 12.8%, to $39.40 in pre-market trading.

TODAY'S FREE FLY STORIES

TEST

DEF Company

20:41
02/19/18
02/19
20:41
02/19/18
20:41
Hot Stocks
technical testing 

technical testing

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ANAB

AnaptysBio

$126.45

6.59 (5.50%)

, SNY

Sanofi

$39.91

0.19 (0.48%)

20:02
02/19/18
02/19
20:02
02/19/18
20:02
Hot Stocks
On The Fly: Top five weekend stock stories »

Catch up on the…

ANAB

AnaptysBio

$126.45

6.59 (5.50%)

SNY

Sanofi

$39.91

0.19 (0.48%)

REGN

Regeneron

$332.15

-1.03 (-0.31%)

SNAP

Snap

$20.42

0.67 (3.39%)

GE

General Electric

$15.05

0.2 (1.35%)

DIS

Disney

$106.53

1.35 (1.28%)

GOOG

Alphabet

$1,094.80

5.28 (0.48%)

GOOGL

Alphabet Class A

$1,095.50

4.14 (0.38%)

LRCX

Lam Research

$187.91

2.2 (1.18%)

C

Citi

$76.82

-0.26 (-0.34%)

CMI

Cummins

$165.60

0.58 (0.35%)

JPM

JPMorgan

$114.68

-0.83 (-0.72%)

JNJ

Johnson & Johnson

$133.15

1.92 (1.46%)

WMT

Walmart

$104.78

1.55 (1.50%)

PFE

Pfizer

$36.26

0.55 (1.54%)

CSCO

Cisco

$44.33

0.25 (0.57%)

ABBV

AbbVie

$118.60

3.7 (3.22%)

PEP

PepsiCo

$111.06

0.09 (0.08%)

MMM

3M

$236.67

1.8 (0.77%)

BMY

Bristol-Myers

$68.96

-0.02 (-0.03%)

UTX

United Technologies

$129.26

-0.74 (-0.57%)

TXN

Texas Instruments

$104.47

-0.1 (-0.10%)

ABT

Abbott

$60.17

0.67 (1.13%)

HOV

Hovnanian

$2.24

0.12 (5.66%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Feb

  • 20

    Feb

  • 21

    Feb

  • 23

    Feb

  • 23

    Feb

  • 25

    Feb

  • 26

    Feb

  • 26

    Feb

  • 27

    Feb

  • 28

    Feb

  • 28

    Feb

  • 01

    Mar

  • 05

    Mar

  • 06

    Mar

  • 06

    Mar

  • 06

    Mar

  • 07

    Mar

  • 07

    Mar

  • 07

    Mar

  • 08

    Mar

  • 08

    Mar

  • 13

    Mar

  • 18

    Mar

  • 25

    Mar

  • 28

    Mar

  • 29

    Mar

  • 29

    Mar

  • 04

    Apr

  • 13

    Apr

  • 23

    Apr

  • 02

    May

  • 03

    May

  • 30

    May

  • 14

    Jul

  • 12

    Oct

CUB

Cubic

19:34
02/19/18
02/19
19:34
02/19/18
19:34
Hot Stocks
Cubic names president, CEO Bradley Feldmann as Chairman of the Board »

Cubic Corporation…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Feb

  • 06

    Mar

  • 07

    Mar

  • 08

    Mar

  • 14

    Jun

HCLP

Hi-Crush Partners

$12.40

0.25 (2.06%)

19:10
02/19/18
02/19
19:10
02/19/18
19:10
Earnings
Breaking Earnings news story on Hi-Crush Partners »

Hi-Crush Partners expects…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Feb

  • 28

    Feb

HCLP

Hi-Crush Partners

$12.40

0.25 (2.06%)

19:08
02/19/18
02/19
19:08
02/19/18
19:08
Earnings
Hi-Crush Partners reports Q4 diluted EPS 47c, consensus 51c »

Reports Q4 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Feb

  • 28

    Feb

FSS

Federal Signal

$19.40

0.15 (0.78%)

19:04
02/19/18
02/19
19:04
02/19/18
19:04
Hot Stocks
Federal Signal declares dividend of 7c per share »

The Board of Directors of…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BCE

BCE

$44.49

-0.02 (-0.04%)

19:03
02/19/18
02/19
19:03
02/19/18
19:03
Hot Stocks
BCE reports results of Series AC, AD Preferred Share conversions »

BCE announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Feb

PRGX

PRGX Global

$7.95

0.35 (4.61%)

18:38
02/19/18
02/19
18:38
02/19/18
18:38
Hot Stocks
PRGX Global announces appointment of new Chief Product Officer »

PRGX Global announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    May

CRMT

America's Car-Mart

$46.25

0.6 (1.31%)

18:37
02/19/18
02/19
18:37
02/19/18
18:37
Earnings
America's Car-Mart reports Q3 revenue $$147M, consensus $136.24M »

Reports Q3 $1.82 per…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Feb

TAX

Liberty Tax

18:30
02/19/18
02/19
18:30
02/19/18
18:30
Hot Stocks
Liberty Tax Service taps Nicole Ossenfort to be CEO »

Liberty Tax, the parent…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TAX

Liberty Tax

18:29
02/19/18
02/19
18:29
02/19/18
18:29
Hot Stocks
Shaun York to be Chief Operating Officer for Liberty Tax Service »

Liberty Tax, the parent…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TAX

Liberty Tax

18:28
02/19/18
02/19
18:28
02/19/18
18:28
Hot Stocks
Liberty Tax names Ryan Dodson Chief Strategy Officer »

Liberty Tax, the parent…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HLX

Helix Energy

18:27
02/19/18
02/19
18:27
02/19/18
18:27
Earnings
Helix Energy reports Q4 EPS 34c, may not compare consensus (1C) »

Reports Q4 revenue $163M,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Feb

EMES

Emerge Energy

$7.77

0.12 (1.57%)

, CNI

Canadian National

$76.18

-0.68 (-0.88%)

18:17
02/19/18
02/19
18:17
02/19/18
18:17
Hot Stocks
Emerge Energy Services responds to industry-wide railroad service issues »

Emerge Energy Services…

EMES

Emerge Energy

$7.77

0.12 (1.57%)

CNI

Canadian National

$76.18

-0.68 (-0.88%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Feb

  • 26

    Feb

  • 28

    Feb

WM

Waste Management

$85.15

1.13 (1.34%)

18:09
02/19/18
02/19
18:09
02/19/18
18:09
Hot Stocks
Waste Management announces cash dividend »

Waste Management…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BRK.A

Berkshire Hathaway

$306,000.00

1.01 (0.00%)

, BRK.B

Berkshire Hathaway

$203.79

-0.11 (-0.05%)

18:07
02/19/18
02/19
18:07
02/19/18
18:07
Hot Stocks
JM announces Eric Cremer as New Chief Human Resources Officer »

Johns Manville, a…

BRK.A

Berkshire Hathaway

$306,000.00

1.01 (0.00%)

BRK.B

Berkshire Hathaway

$203.79

-0.11 (-0.05%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TWX

Time Warner

$95.37

0.38 (0.40%)

, CMCSA

Comcast

$39.79

-0.29 (-0.72%)

18:03
02/19/18
02/19
18:03
02/19/18
18:03
Hot Stocks
Box Office Battle: 'Black Panther' wins Presidents Day box office »

Disney (DIS) and Marvel…

TWX

Time Warner

$95.37

0.38 (0.40%)

CMCSA

Comcast

$39.79

-0.29 (-0.72%)

CMCSK

Comcast

SNE

Sony

$49.55

0.74 (1.52%)

FOX

21st Century Fox

$37.04

0.39 (1.06%)

FOXA

21st Century Fox

$37.46

0.5 (1.35%)

LGF.A

Lionsgate

$29.33

0.87 (3.06%)

DIS

Disney

$106.53

1.35 (1.28%)

VIAB

Viacom

$33.50

-0.43 (-1.27%)

VIA

Viacom

$39.90

0.55 (1.40%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Feb

  • 26

    Feb

  • 01

    Mar

  • 05

    Mar

  • 19

    Mar

  • 23

    Apr

SPN

Superior Energy

$8.91

-0.03 (-0.34%)

17:46
02/19/18
02/19
17:46
02/19/18
17:46
Earnings
Superior Energy reports Q4 adjusted EPS (33c), consensus (32c) »

Reports Q4 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Feb

  • 28

    Feb

QCOM

Qualcomm

$64.85

-0.43 (-0.66%)

, SSNLF

Samsung

17:40
02/19/18
02/19
17:40
02/19/18
17:40
Hot Stocks
Qualcomm, Samsung achieve multi-vendor 5G NR interoperability on path to trials »

KT Corporation, Qualcomm…

QCOM

Qualcomm

$64.85

-0.43 (-0.66%)

SSNLF

Samsung

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Mar

HAL

Halliburton

$47.50

0.61 (1.30%)

17:37
02/19/18
02/19
17:37
02/19/18
17:37
Hot Stocks
Halliburton declares Q1 dividend of 18c »

Halliburton announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Feb

GILD

Gilead

$80.70

-0.85 (-1.04%)

, MRK

Merck

$56.29

0.3 (0.54%)

17:10
02/19/18
02/19
17:10
02/19/18
17:10
Periodicals
Gilead wins reversal of hepatitis C drug patent verdict, Reuters says »

A federal judge in…

GILD

Gilead

$80.70

-0.85 (-1.04%)

MRK

Merck

$56.29

0.3 (0.54%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Feb

  • 08

    Mar

  • 25

    Mar

  • 03

    Apr

  • 04

    Apr

  • 23

    Apr

  • 23

    Apr

  • 23

    Oct

FB

Facebook

$177.36

-2.6 (-1.44%)

17:05
02/19/18
02/19
17:05
02/19/18
17:05
Periodicals
Facebook to verify ads with postcards following Russian meddling, AP says »

Facebook will soon start…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Feb

  • 26

    Feb

  • 28

    Feb

  • 07

    Mar

  • 18

    Mar

MOS

Mosaic

$25.43

-0.43 (-1.66%)

16:58
02/19/18
02/19
16:58
02/19/18
16:58
Earnings
Mosaic reports Q4 adjusted EPS 34c, consensus 29c »

Q4 loss per share was…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Feb

  • 25

    Feb

  • 25

    Feb

  • 28

    Feb

TSE

Trinseo

$81.05

-0.3 (-0.37%)

16:51
02/19/18
02/19
16:51
02/19/18
16:51
Earnings
Breaking Earnings news story on Trinseo »

Trinseo raises FY18…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Feb

TSE

Trinseo

$81.05

-0.3 (-0.37%)

16:48
02/19/18
02/19
16:48
02/19/18
16:48
Earnings
Breaking Earnings news story on Trinseo »

Trinseo sees Q1 adjusted…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Feb

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.